Latest Kidney Cancer News

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population

Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) – Scientific Reports

Thermal Ablation vs Surgery for Stage T1a RCC Offers Similar Cancer-Specific Survival – Oncology Nurse Advisor
Kidney Cancer News elsewhere on the Web

BackgroundAnoikis is a form of programmed cell death essential for preventing cancer metastasis. In some solid cancer, anoikis resistance can facilitate tumo...

"The positive trends emerging from the ongoing phase 1 trial of BMC128, particularly in combination with nivolumab, underscore the transformative potential of microbiome-based therapeutics in oncology,” says Gal Markel, MD, PhD, MBA.

Immune checkpoint inhibitors have transformed the treatment landscape of many cancers, including melanoma and renal cell carcinoma (RCC). Randomised trials are evaluating outcomes from reduced ICI treatment schedules with the aim of improving quality of life, tolerability, and ...

Palbociclib is under clinical development by Pfizer and currently in Phase II for Renal Cell Carcinoma.

World Kidney Cancer Day was first observed on June 15, 2017. This is a cancer that begins in your kidneys. There are certain factors that increase an individual’s risk of developing kidney cancer. Read on to know about some of the common risk factors that might lead one to develop the ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

LG Chem and AVEO Oncology announced the enrolment of the first subject in Phase I study of LB-LR1109, an anti-cancer investigational drug.

Kidney cancer, a type of urogenital cancer, imposes a high burden on patients. Despite this, no recent research has evaluated the burden of this type of cancer in the Middle East and North Africa (MENA) region. This study explored the burden of kidney cancer from 1990 to 2019 according to age, ...

NPX-267 is under clinical development by NextPoint Therapeutics and currently in Phase I for Renal Cell Carcinoma.

Nivolumab/cabozantinib combination therapy showed consistent benefits across various subgroups in patients with advanced renal cell carcinoma (RCC).
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.





